4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-15-044135
$PVCTCIK 0000315545operating
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 1:44 PM ET
Size
10.8 KB
Accession
0001140361-15-044135
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-12-09$0.94/sh+138,831$130,501→ 1,251,163 total - Exercise/Conversion
Common Stock
2015-12-09$0.94/sh+6,383$6,000→ 190,503 total(indirect: By 401(k)) - Exercise/Conversion
Stock Option (right to buy)
2015-12-09−145,214→ 0 totalExercise: $0.94From: 2006-12-09Exp: 2015-12-09→ Common Stock (145,214 underlying) - Award
Stock Option (right to buy)
2015-12-09+400,000→ 400,000 totalExercise: $0.75From: 2015-12-09Exp: 2025-12-09→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option, representing a right to purchase a total of 175,000 shares, became exercisable in three equal installments beginning on December 9, 2006, which was the first anniversary of the date on which the option was granted.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 1:44 PM ET
- Size
- 10.8 KB